Association between the Immunophenotype of Peripheral Blood from mCRPC Patients and the Outcomes of Radium-223 Treatment

(1) Background: Prostate cancer is the second most common cancer in men, with androgen suppression as the standard treatment. Despite initially responding to castration, most metastatic prostate cancer patients eventually experience progression. In these cases, Radium-223 is the chosen treatment. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantó, Elisabet, Anguera, Georgia, Jiménez, Natalia, Mellado, Begoña, Ramírez, Ona, Mariscal, Anais, Maroto, Pablo, Vidal, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340498/
https://www.ncbi.nlm.nih.gov/pubmed/37443615
http://dx.doi.org/10.3390/diagnostics13132222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340498/
https://www.ncbi.nlm.nih.gov/pubmed/37443615
http://dx.doi.org/10.3390/diagnostics13132222

Ejemplares similares